Genomic Health Announces Publication Of Study Of Oncotype DX(R) In Node-Positive Brea

[News]

Genomic Health, Inc. (Nasdaq: GHDX) announced that The Lancet Oncology published positive results from a study of Oncotype DX(®) in postmenopausal women with node-positive, estrogen receptor-positive breast cancer conducted by the Southwest Oncology Group (SWOG), a National Cancer Institute-supported clinical trials cooperative group...

More... (http://www.medicalnewstoday.com/articles/173685.php)